Sarah Caulfield

537 total citations
42 papers, 353 citations indexed

About

Sarah Caulfield is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Sarah Caulfield has authored 42 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 14 papers in Surgery. Recurrent topics in Sarah Caulfield's work include Renal cell carcinoma treatment (22 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Sarah Caulfield is often cited by papers focused on Renal cell carcinoma treatment (22 papers), Cancer Immunotherapy and Biomarkers (17 papers) and Bladder and Urothelial Cancer Treatments (13 papers). Sarah Caulfield collaborates with scholars based in United States, United Kingdom and Ireland. Sarah Caulfield's co-authors include Mehmet Asım Bilen, Bradley Curtis Carthon, Ömer Küçük, Christine Davis, Dylan J. Martini, Yuan Liu, Wayne Harris, Jacqueline T. Brown, Viraj A. Master and Bassel Nazha and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Oncologist.

In The Last Decade

Sarah Caulfield

39 papers receiving 352 citations

Peers

Sarah Caulfield

ONCOL

PRM

SURGE

EPIDE

Adithya Chennamadhavuni United States

Mahsa Ahadi Australia

Ashish Manne United States

Emma Zattarin Italy

Jamil Asselah Canada

Enzo Veltri Italy

Liusheng Wu China

Keita Uchino Japan

William Leslie United States

Anas Al-Janadi United States

Adithya Chennamadhavuni United States

Sarah Caulfield

344 ×1.5

ONCOL

121 ×0.7

PRM

41 ×0.6

SURGE

85 ×1.4

34 ×0.8

EPIDE

Citations per year, relative to Sarah Caulfield Sarah Caulfield (= 1×) peers Adithya Chennamadhavuni

Countries citing papers authored by Sarah Caulfield

Since Specialization

Citations

This map shows the geographic impact of Sarah Caulfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Caulfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Caulfield more than expected).

Fields of papers citing papers by Sarah Caulfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Caulfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Caulfield. The network helps show where Sarah Caulfield may publish in the future.

Co-authorship network of co-authors of Sarah Caulfield

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Caulfield. A scholar is included among the top collaborators of Sarah Caulfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Caulfield. Sarah Caulfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caulfield, Sarah, et al.. (2026). Chronic inflammatory enteropathy without moderate to severe hypoalbuminemia: long-term outcome in 60 dogs. Journal of Veterinary Internal Medicine. 40(1).

Liu, Yuan, Bassel Nazha, Jacqueline T. Brown, et al.. (2025). Phase 2 study of perioperative lenvatinib (L) with pembrolizumab (P) in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 555–555.

Liu, Yuan, Bassel Nazha, Jacqueline T. Brown, et al.. (2025). Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology. 17. 22760979–22760979. 1 indexed citations

Sanda, Gregory E., Julie M. Shabto, Subir Goyal, et al.. (2023). Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. The Oncologist. 28(12). 1072–1078. 7 indexed citations

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2022). Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. SHILAP Revista de lepidopterología. 5(3). 52–57. 1 indexed citations

Smith, Katherine E., Jacqueline T. Brown, Sarah Caulfield, et al.. (2022). Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer. Urologic Oncology Seminars and Original Investigations. 40(6). 271.e9–271.e18. 13 indexed citations

Caulfield, Sarah, Dylan J. Martini, Jacqueline T. Brown, et al.. (2022). Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy. Frontiers in Endocrinology. 13. 779915–779915. 28 indexed citations

Caulfield, Sarah, Simon L. Priestnall, & Aarti Kathrani. (2021). Concordance of the Histopathologic Diagnosis of Concurrent Duodenal and Ileal Biopsy Specimens in Dogs. Animals. 11(10). 2938–2938. 5 indexed citations

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in Oncology. 11. 701345–701345. 7 indexed citations

10.

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in Oncology. 11. 707050–707050. 26 indexed citations

11.

Martini, Dylan J., Yuan Liu, Julie M. Shabto, et al.. (2021). Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer Treatment and Research Communications. 28. 100393–100393. 4 indexed citations

12.

Martini, Dylan J., Yuan Liu, Julie M. Shabto, et al.. (2021). Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients. Clinical Genitourinary Cancer. 20(1). 53–59. 7 indexed citations

13.

Ravindranathan, Deepak, Yuan Liu, Dylan J. Martini, et al.. (2021). Clinical outcomes in metastatic renal cell carcinoma (mRCC) treated with combination of nivolumab and cabozantinib (nivo-cabo) in the salvage setting.. Journal of Clinical Oncology. 39(15_suppl). e16570–e16570. 1 indexed citations

14.

Shabto, Julie M., Dylan J. Martini, Yuan Liu, et al.. (2020). Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer Medicine. 9(8). 2752–2760. 8 indexed citations

15.

Martini, Dylan J., Yuan Liu, Julie M. Shabto, et al.. (2020). Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C).. Journal of Clinical Oncology. 38(6_suppl). 734–734. 1 indexed citations

16.

Patel, Urvi & Sarah Caulfield. (2019). Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer. Journal of the Advanced Practitioner in Oncology. 10(5). 501–507. 5 indexed citations

17.

Caulfield, Sarah, et al.. (2019). Olaparib: A Novel Therapy for Metastatic Breast Cancer in Patients With a BRCA1/2 Mutation. Journal of the Advanced Practitioner in Oncology. 10(2). 167–174. 48 indexed citations

18.

Caulfield, Sarah, et al.. (2018). Nomograms are key decision-making tools in prostate cancer radiation therapy. Urologic Oncology Seminars and Original Investigations. 36(6). 283–292. 26 indexed citations

19.

Greenwell, Irl Brian, Sarah Caulfield, Jeffrey M. Switchenko, et al.. (2017). Outcomes in Mantle Cell Lymphoma for Elderly Patients Undergoing Autologous Stem Cell Transplant in CR1. Biology of Blood and Marrow Transplantation. 23(3). S265–S266. 1 indexed citations

20.

Duncan, John S., Sarah Caulfield, Adam Clark, et al.. (2010). PTH-071 A multidisciplinary virtual biologics clinic: is it worthwhile?. A152.1–A152. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact